UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.

10/06/2023 10/06/2023

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model

Psilocybin has the potential to be a cost-effective therapy for severe depression. This depends on the level of psychological support that is given to patients receiving psilocybin and the price of the drug itself. Further data on long-term outcomes are required to improve the evidence base.

16/01/2023 16/01/2023

Is the high cost of psychedelic therapy worth it?

In this column I will examine the costs and benefits of psychedelic-assisted therapy,

10/12/2022 10/12/2022

The economics of psychedelic-assisted therapies: A research agenda

We describe six types of economic analyses and their rationale for decisions and planning including the needs of health care payers.